Skip to content

Esketamine: all studies

Page 40 of 123: studies 391 to 400 of 1,225, newest first. Back to the esketamine overview

Research

Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study.

European Neuropsychopharmacology April 1, 2025 Eduard Vieta, Nahida Ahmed, Celso Arango et al. 12 citations

Patients with treatment resistant depression (TRD) experience a greater negative impact on their functioning and productivity at home and in the workplace versus treatment-responsive patients. Here, we report the effects of esketamine nasal spray (NS) versus quetiapine extended release (XR) on functioning, work productivity and activity impairment. ESCAPE‑TRD (NCT04338321) was a 32-week...

Esketamine alleviated cardiomyocyte ferroptosis induced by oxygen-glucose deprivation/reoxygenation (OGD/R) via cyclic GMP-AMP synthase interactor.

Cytotechnology April 1, 2025 Jianjun Ouyang, Weiqiang Xiao, Di Wu et al. 8 citations

The use of tourniquets (TQ) during the total knee arthroplasty (TKA) induced ischemia-reperfusion (I/R) injury in the limb, resulting in the release of inflammatory cytokines and reactive oxygen species (ROS), therefore leading to myocardial damage. This study aimed to investigate the effects and molecular mechanism of Esketamine on myocardial injury (MI) caused by TQ-induced I/R injury. A...

DOI: 10.1007/s10616-025-00723-9 (opens in new tab) Full text (opens in new tab) Cardiomyocyte Ogd/r Sting #cardioprotection heart protection +6

Effect of esketamine on postoperative depression in women with breast cancer and preoperative depressive symptoms: The EASE randomized trial.

Journal of clinical anesthesia April 1, 2025 Qingfeng Wei, Mengmeng Li, Qiuling Du et al. 10 citations

To determine whether intraoperative low-dose esketamine ameliorates depression in women having breast cancer surgery. A prospective single-center double blind randomized placebo-controlled trial. Perioperative period, operating room, post anesthesia care unit and hospital ward. 108 women 18-65 years old who were scheduled for elective breast cancer surgery. All had preoperative depressive...

Investigating the Mechanisms of Esketamine in Treating Propofol-Induced Cognitive Impairment in Elderly Rats.

Discovery medicine April 1, 2025 Jieru Zhang, Guofeng Xu, Xiaoli Wang et al.

Common cognitive impairment in the elderly may be aggravated by the anesthetic propofol, whereas the mammalian target of rapamycin protein (mTOR)-brain-derived neurotrophic factor (BDNF) pathway and autophagy regulation play a key role in neuroprotection. In this study, we investigated whether esketamine can improve propofol-induced cognitive impairment in aged rats by affecting these...

DOI: 10.24976/Discov.Med.202537195.60 (opens in new tab) Full text (opens in new tab) Esketamine Mtor-bdnf pathway Neuronal autophagy Postoperative cognitive dysfunction +6

Inhibition of autophagy by esketamine attenuates hypoxia/reoxygenation injury in cardiomyocytes via inhibition of Ca2+/CaMKKβ/AMPK/mTOR pathway by down-regulation of transient receptor potential vanilloid 1 expression.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society April 1, 2025 Y Zhang, Q M Lu, H C Hu et al.

This research sought to determine the influence of esketamine (ESK) on hypoxia/reoxygenation (H/R) injury in cardiomyocytes by blocking autophagy via the transient receptor potential vanilloid type 1 (TRPV1)/ Ca2+/ calmodulin-dependent protein kinase β (CaMKKβ)/ adenosine monophosphate (AMP)-activated protein kinase (AMPK)/ mammalian target of rapamycin (mTOR) pathway. H9c2 cardiomyocytes were...

[Esketamine Alleviates Postoperative Depressive Symptoms in Frail Elderly Patients Undergoing Thoracoscopic Radical Resection of Lung Cancer: A Randomized Double-Blind Controlled Trial].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition March 20, 2025 Congli Zhang, Yan Yan, Junjie Ma et al. 1 citation

To investigate the effect of esketamine on postoperative depression in frail elderly patients undergoing thoracoscopic radical resection of lung cancer. A total of 88 frail elderly patients undergoing elective thoracoscopic radical resection of lung cancer were assigned randomly (using a randomization table) and in a double-blind way (blinding applies to both researchers and patients) to an...

DOI: 10.12182/20250360202 (opens in new tab) Full text (opens in new tab) Frail elderly patients Postoperative depressive state Thoracoscopy Esketamine: esketamine +8

Person-centred care during treatment with nasal esketamine - a qualitative study.

BMC Nursing March 14, 2025 Lina Klysing, Ingrid Larsson, Katrin Häggström Westberg 2 citations

Patients suffering from treatment-resistant depression may be treated with nasal esketamine. The treatment requires administration in a healthcare facility and monitoring by a nurse. Existing research has mainly focused on the clinical effect of nasal esketamine, while less is known about patients' experiences of treatment. A person-centred framework provides valuable insights into care and...

DOI: 10.1186/s12912-025-02943-y (opens in new tab) Full text (opens in new tab) Intranasal ketamine Nursing Nasal esketamine Person-centred care +4

Intravenous esketamine in pediatric Rett syndrome: An open-label, early phase 1 pilot study.

Molecular therapy. Methods & clinical development March 13, 2025 Huiping Li, Shu Liu, Caimei Lin et al. 5 citations

Rett syndrome (RTT) is a severe neurodevelopmental disorder. N-Methyl-d-aspartate receptor (NMDAR) antagonism has shown therapeutic potential in preclinical RTT models. We performed a pilot study to explore whether intravenous esketamine, an NMDAR antagonist, alleviates the symptoms of pediatric RTT. This was a prospective, single-arm, single-site, open-label, early phase 1 pilot study. Three...

DOI: 10.1016/j.omtm.2025.101413 (opens in new tab) Full text (opens in new tab) Esketamine N-methyl-d-aspartate receptor antagonist Rett syndrome Efficiency +6

Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study.

Journal of the American Academy of Child & Adolescent Psychiatry March 7, 2025 Colette Kosik-Gonzalez, Dong-Jing Fu, Li Nancy Chen et al. 14 citations

To evaluate the efficacy, safety, and tolerability of esketamine nasal spray vs psychoactive placebo (oral midazolam) in rapidly reducing depressive symptoms in adolescents with major depressive disorder at imminent risk for suicide. This double-blind, double-dummy, phase 2b study randomized (1:1:1:2) 147 adolescents (12 to <18 years old) to esketamine (28, 56, or 84 mg) or midazolam twice...

Effect of esketamine on reducing postpartum pain and depression.

World Journal of Clinical Cases March 6, 2025 Brandon P Lucke-Wold, Armin Karamian 9 citations

In this editorial, we comment on a recent article by Chen et al, that addressed the effect of intraoperative injection of esketamine on postoperative analgesia and postoperative rehabilitation after cesarean section. Poor management of post-cesarean pain is associated with decreased maternal care for the baby, longer hospitalization, and higher risk of developing postpartum depression....

DOI: 10.12998/wjcc.v13.i7.100422 (opens in new tab) Full text (opens in new tab) Cesarean-section c-section Esketamine-therapy ketamine treatment Postpartum-depression postnatal depression Baby blues +8